Cargando…
The stability of R-spine defines RAF inhibitor resistance: A comprehensive analysis of oncogenic BRAF mutants with in-frame insertion of αC-β4 loop
Although targeting BRAF mutants with RAF inhibitors has achieved promising outcomes in cancer therapy, drug resistance remains a remarkable challenge, and underlying molecular mechanisms are not fully understood. Here, we characterized a previously unknown group of oncogenic BRAF mutants with in-fra...
Autores principales: | Yap, Jiajun, Deepak, R. N. V. Krishna, Tian, Zizi, Ng, Wan Hwa, Goh, Kah Chun, Foo, Alicia, Tee, Zi Heng, Mohanam, Manju Payini, Sim, Yuen Rong M., Degirmenci, Ufuk, Lam, Paula, Chen, Zhongzhou, Fan, Hao, Hu, Jiancheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189578/ https://www.ncbi.nlm.nih.gov/pubmed/34108213 http://dx.doi.org/10.1126/sciadv.abg0390 |
Ejemplares similares
-
Drug resistance in targeted cancer therapies with RAF inhibitors
por: Degirmenci, Ufuk, et al.
Publicado: (2021) -
Targeting Aberrant RAS/RAF/MEK/ERK Signaling for Cancer Therapy
por: Degirmenci, Ufuk, et al.
Publicado: (2020) -
The dimer-dependent catalytic activity of RAF family kinases is revealed through characterizing their oncogenic mutants
por: Yuan, Jimin, et al.
Publicado: (2018) -
RAF inhibitors transactivate RAF dimers and ERK signaling in cells with wild-type BRAF
por: Poulikakos, Poulikos I., et al.
Publicado: (2010) -
BRAF(V600E) mutation together with loss of Trp53 or pTEN drives the origination of hairy cell leukemia from B-lymphocytes
por: Yap, Jiajun, et al.
Publicado: (2023)